ETNB - 89bio, Inc.
IEX Last Trade
8.01
0.030 0.375%
Share volume: 28,589
Last Updated: Thu 26 Dec 2024 08:30:06 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$7.98
0.03
0.38%
Summary score
27%
Profitability
25%
Dept financing
25%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-4.2%
Return on assets
-20.54%
Return on sales
0%
Return on invested capital
200.47%
Total debt ratio
104.42%
Debt ratio change over timeo
-0.95%
Current Ratio
10.01%
Quick Ratio
0%
Cash Position Ratio
10.05%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.2%
Return on assets
-20.54%
Return on sales
0%
Return on invested capital
200.47%
Total debt ratio
104.42%
Debt ratio change over timeo
-0.95%
Current Ratio
10.01%
Quick Ratio
0%
Cash Position Ratio
10.05%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-16.87%
Return on assets
-15.25%
Return on sales
0%
Return on invested capital
213.24%
Total debt ratio
8.87%
Debt ratio change over time
-0.94%
Current Ratio
11.09%
Quick Ratio
0%
Cash Position Ratio
10.05%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-113.18%
Return on assets
-108.48%
Return on sales
0%
Return on invested capital
96.44%
Total debt ratio
-94.89%
Debt ratio change over time
-0.95%
Current Ratio
8.97%
Quick Ratio
0%
Cash Position Ratio
6.16%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ETNB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.2% | -3.05% | 11.55% | 6.27% |
| Return on assets | -20.54% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 200.47% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 104.42% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.95% | 6.09% | 6.03% | 1.53% |
| Dept financing | 25% | 49% | 42% | 13% |
| Current Ratio | 10.01% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.05% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 16% | 35% | 35% |
| Short-term ratios | ETNB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -4.2% | -25.62% | 17.94% | 7.14% |
| Return on assets | -20.54% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 200.47% | 8.14% | 7.17% | 18.16% |
| Profitability | 25% | 39% | 70% | 60% |
| Total debt ratio | 104.42% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.95% | -23.44% | 9.66% | 0.6% |
| Dept financing | 25% | 25% | 45% | 8% |
| Current Ratio | 10.01% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 10.05% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 26% | 22% | 37% |